Towards modelling of the environmental fate of pharmaceuticals using the QSPR-MM scheme
暂无分享,去创建一个
Hiroshi Yamamoto | Tomasz Puzyn | Noriyuki Suzuki | Agnieszka Gajewicz | Takeo Sakurai | Norihisa Tatarazako | Aleksandra Mostrag-Szlichtyng | Yasunobu Aoki | Haruna Watanabe | Toru Kawai | Karolina Jagiello | Yoshitaka Imaizumi | Kaoruko Mizukawa | T. Puzyn | T. Kawai | Kaoruko Mizukawa | A. Gajewicz | K. Jagiello | Hiroshi Yamamoto | Haruna Watanabe | N. Tatarazako | N. Suzuki | A. Mostrag-Szlichtyng | Y. Aoki | T. Sakurai | Yoshitaka Imaizumi
[1] Katarzyna Odziomek,et al. A new metric for long-range transport potential of chemicals. , 2014, Environmental science & technology.
[2] D. Mackay,et al. Application of the QWASI (Quantitative Water Air Sediment Interaction) fugacity model to the dynamics of organic and inorganic chemicals in lakes , 1989 .
[3] John C. Dearden,et al. QSPR Correlation of Melting Point for Drug Compounds Based on Different Sources of Molecular Descriptors , 2006, J. Chem. Inf. Model..
[4] D. Mackay,et al. Finding fugacity feasible , 1979 .
[5] K. Carroll,et al. Exposure to 17 alpha-ethinylestradiol and bisphenol A--effects on larval moulting and mouthpart structure of Chironomus riparius. , 2003, Ecotoxicology and environmental safety.
[6] J. Dearden,et al. Linear QSAR regression models for the prediction of bioconcentration factors by physicochemical properties and structural theoretical molecular descriptors. , 2007, Chemosphere.
[7] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[8] Tomasz Puzyn,et al. Global versus local QSPR models for persistent organic pollutants: balancing between predictivity and economy , 2011 .
[9] Lyn Denison,et al. Stockholm Convention on Persistent Organic Pollutants , 2013 .
[10] Beate I Escher,et al. A screening level fate model of organic contaminants from advanced water treatment in a potable water supply reservoir. , 2011, Water research.
[11] D Mackay,et al. The evolution of mass balance models of persistent organic pollutant fate in the environment. , 1999, Environmental pollution.
[12] Søren Brunak,et al. Prediction of pH-Dependent Aqueous Solubility of Druglike Molecules , 2006, J. Chem. Inf. Model..
[13] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[14] John Struger,et al. Aquivalence revisited--new model formulation and application to assess environmental fate of ionic pharmaceuticals in Hamilton Harbour, Lake Ontario. , 2011, Environment international.
[15] Peter Shanahan,et al. Screening analysis of human pharmaceutical compounds in U.S. surface waters. , 2004, Environmental science & technology.
[16] Tomasz Puzyn,et al. Predicting logarithmic values of the subcooled liquid vapor pressure of halogenated persistent organic pollutants with QSPR: How different are chlorinated and brominated congeners? , 2010 .
[17] McKone. CalTOX: A multimedia total-exposure model for hazardous-wastes sites. Part 3, The multiple-pathway exposure model , 1992 .
[18] Jerzy Leszczynski,et al. Direct QSPR: the most efficient way of predicting organic carbon/water partition coefficient (log KOC) for polyhalogenated POPs , 2014, Structural Chemistry.
[19] Kunal Roy,et al. Predictive toxicology using QSAR: A perspective , 2010 .
[20] Simon Webb,et al. Exposure simulation for pharmaceuticals in European surface waters with GREAT-ER. , 2002, Toxicology letters.
[21] Annemarie P van Wezel,et al. Comparison of two screening level risk assessment approaches for six disinfectants and pharmaceuticals. , 2002, Chemosphere.
[22] Kd Tripathi. Pharmacological Classification of Drugs with Doses and Preparations , 2008 .
[23] Christian G Daughton,et al. Green pharmacy and pharmEcovigilance: prescribing and the planet , 2011, Expert review of clinical pharmacology.
[24] P Lebrun,et al. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release. , 1984, Research communications in chemical pathology and pharmacology.
[25] Samuel H Yalkowsky,et al. Prediction of aqueous solubility from SCRATCH. , 2010, International journal of pharmaceutics.
[26] Jörg Huwyler,et al. Computational aqueous solubility prediction for drug-like compounds in congeneric series. , 2008, European journal of medicinal chemistry.
[27] Ulf Norinder,et al. Global and Local Computational Models for Aqueous Solubility Prediction of Drug‐Like Molecules. , 2004 .
[28] Sean Ekins,et al. Troubleshooting computational methods in drug discovery. , 2010, Journal of pharmacological and toxicological methods.
[29] Tomasz Puzyn,et al. QSPR-based estimation of the atmospheric persistence for chloronaphthalene congeners , 2008 .
[30] P Gramatica,et al. Modelling physico-chemical properties of (benzo)triazoles, and screening for environmental partitioning. , 2011, Water research.
[31] Eduardo A. Castro,et al. QSPR Studies on Aqueous Solubilities of Drug-Like Compounds , 2009, International journal of molecular sciences.
[32] Andrew G. Garrow,et al. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries. , 2012, Drug discovery today.
[33] Peter A. Vanrolleghem,et al. A geo-referenced aquatic exposure prediction methodology for ‘down-the-drain’ chemicals , 1997 .
[34] J Devillers,et al. European Union System for the Evaluation of Substances (EUSES). Principles and structure. , 1997, Chemosphere.
[35] Glen Huntly,et al. Environmental footprint of pharmaceuticals : the significance of factors beyond direct excretion to sewers , 2010 .
[36] Kevin C Jones,et al. Modelling the fate of persistent organic pollutants in Europe: parameterisation of a gridded distribution model. , 2004, Environmental pollution.
[37] Paola Gramatica,et al. On the development and validation of QSAR models. , 2013, Methods in molecular biology.
[38] S. Jørgensen,et al. Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.
[39] Dong-Sheng Cao,et al. Prediction of aqueous solubility of druglike organic compounds using partial least squares, back‐propagation network and support vector machine , 2010 .
[40] Anna-Karin Johansson,et al. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. , 2006, The Science of the total environment.
[41] Jahan B. Ghasemi,et al. QSPR prediction of aqueous solubility of drug-like organic compounds. , 2007, Chemical & pharmaceutical bulletin.
[42] Miriam Diamond,et al. Models of multi-media partitioning of multi-species chemicals: The fugacity/aquivalence approach , 1992 .
[43] Tomasz Puzyn,et al. On the replacement of empirical parameters in multimedia mass balance models with QSPR data. , 2011, Journal of hazardous materials.
[44] M Matthies,et al. GREAT-ER: a new tool for management and risk assessment of chemicals in river basins. Contribution to GREAT-ER #10. , 2001, Water science and technology : a journal of the International Association on Water Pollution Research.
[45] Charles R. Tyler,et al. Long-Term Exposure to Environmental Concentrations of the Pharmaceutical Ethynylestradiol Causes Reproductive Failure in Fish , 2004, Environmental health perspectives.
[46] Frank Wania,et al. Evaluating the environmental fate of pharmaceuticals using a level III model based on poly-parameter linear free energy relationships. , 2006, The Science of the total environment.
[47] Yuichi Moriguchi,et al. Geo-referenced multimedia environmental fate model (G-CIEMS): model formulation and comparison to the generic model and monitoring approaches. , 2004, Environmental science & technology.
[48] D Mackay,et al. BETR North America: A regionally segmented multimedia contaminant fate model for North America , 2001, Environmental science and pollution research international.
[49] Carina Carlsson,et al. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients. , 2006, The Science of the total environment.
[50] E. Thurman,et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.
[51] D. Epel,et al. Nitromusk and Polycyclic Musk Compounds as Long-Term Inhibitors of Cellular Xenobiotic Defense Systems Mediated by Multidrug Transporters , 2004, Environmental health perspectives.
[52] D Mackay,et al. A model for p-aminobenzoic acid ester narcosis in goldfish. , 1985, Journal of pharmaceutical sciences.
[53] Tomasz Puzyn,et al. Predicting enthalpy of vaporization for Persistent Organic Pollutants with Quantitative Structure–Property Relationship (QSPR) incorporating the influence of temperature on volatility , 2014 .
[54] B. Ansell,et al. Acetazolamide in Treatment of Epilepsy , 1956, British medical journal.
[55] Tomasz Puzyn,et al. How do the partitioning properties of polyhalogenated POPs change when chlorine is replaced with bromine? , 2008, Environmental science & technology.
[56] Yi Li,et al. Prediction of aqueous solubility of organic compounds using a quantitative structure-property relationship. , 2002, Journal of pharmaceutical sciences.
[57] D. Grandjean,et al. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. , 2005, Water research.
[58] Z R Li,et al. Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods. , 2006, Journal of molecular graphics & modelling.
[59] K. Fent,et al. Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.
[60] E. Cooper,et al. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. , 2008, The Science of the total environment.
[61] J. Rominger,et al. Modeling the fate of down-the-drain chemicals in rivers: An improved software for GREAT-ER , 2006, Environ. Model. Softw..
[62] M. G. West,et al. Inhibition of Salmonella Cultures by Streptomycin.∗ , 1945, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[63] Emilio Benfenati,et al. In silico methods to predict drug toxicity. , 2013, Current opinion in pharmacology.